Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel

Fanchao Meng, Yating Sun, Robert J. Lee, Guiyuan Wang, Xiaolong Zheng, Huan Zhang, Yige Fu, Guojun Yan, Yifan Wang, Weiye Deng, Emily Parks, Betty Y.S. Kim, Zhaogang Yang, Wen Jiang, Lesheng Teng

Research output: Contribution to journalArticle

Abstract

Microfluidic technology (MF) has improved the formulation of nanoparticles (NPs) by achieving uniform particle size distribution, controllable particle size, and consistency. Moreover, because liquid mixing can be precisely controlled in the pores of the microfluidic chip, maintaining high mixing efficiency, MF exerts higher of NP encapsulation efficiency (EE) than conventional methods. MF-NPs-cabazitaxel (CTX) particles (MF-NPs-CTX) were first prepared by encapsulating CTX according to MF. Folate (FA)- Polyethylene glycol (PEG)-NPs-CTX particles (FA-PEG-NPs-CTX) were formulated by connecting FA to MF-NPs-CTX to endow NPs with targeted delivery capability. Accordingly, the mean particle size of FA-PEG-NPs-CTX increased by approximately 25 nm, as compared with MF-NPs-CTX. Upon morphological observation of FA-PEG-NPs-CTX and MF-NPs-CTX by transmission electron microscopy (TEM), all NPs were spherical and particle size distribution was uniform. Moreover, the increased delivery efficiency of CTX in vitro and its strong tumor inhibition in vivo indicated that FA-PEG-NPs-CTX had a powerful tumor-suppressive effect both in vitro and in vivo. In vivo imaging and pharmacokinetic data confirmed that FA-PEG-NPs-CTX had good drug delivery efficiency. Taken together, FA-PEG-NPs-CTX particles prepared using MF showed high efficient and targeted drug delivery and may have a considerable driving effect on the clinical application of targeting albumin NPs.

Original languageEnglish (US)
Article number1571
JournalCancers
Volume11
Issue number10
DOIs
StatePublished - Oct 2019

Fingerprint

Albumin Receptors
Microfluidics
Folic Acid
Nanoparticles
Technology
Particle Size
cabazitaxel

Keywords

  • Albumin nanoparticle
  • Cabazitaxel
  • Folate receptor
  • Microfluidic

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Meng, F., Sun, Y., Lee, R. J., Wang, G., Zheng, X., Zhang, H., ... Teng, L. (2019). Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel. Cancers, 11(10), [1571]. https://doi.org/10.3390/cancers11101571

Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel. / Meng, Fanchao; Sun, Yating; Lee, Robert J.; Wang, Guiyuan; Zheng, Xiaolong; Zhang, Huan; Fu, Yige; Yan, Guojun; Wang, Yifan; Deng, Weiye; Parks, Emily; Kim, Betty Y.S.; Yang, Zhaogang; Jiang, Wen; Teng, Lesheng.

In: Cancers, Vol. 11, No. 10, 1571, 10.2019.

Research output: Contribution to journalArticle

Meng, F, Sun, Y, Lee, RJ, Wang, G, Zheng, X, Zhang, H, Fu, Y, Yan, G, Wang, Y, Deng, W, Parks, E, Kim, BYS, Yang, Z, Jiang, W & Teng, L 2019, 'Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel', Cancers, vol. 11, no. 10, 1571. https://doi.org/10.3390/cancers11101571
Meng, Fanchao ; Sun, Yating ; Lee, Robert J. ; Wang, Guiyuan ; Zheng, Xiaolong ; Zhang, Huan ; Fu, Yige ; Yan, Guojun ; Wang, Yifan ; Deng, Weiye ; Parks, Emily ; Kim, Betty Y.S. ; Yang, Zhaogang ; Jiang, Wen ; Teng, Lesheng. / Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel. In: Cancers. 2019 ; Vol. 11, No. 10.
@article{3efa4566bd47499eaa60ced7eac06f6e,
title = "Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel",
abstract = "Microfluidic technology (MF) has improved the formulation of nanoparticles (NPs) by achieving uniform particle size distribution, controllable particle size, and consistency. Moreover, because liquid mixing can be precisely controlled in the pores of the microfluidic chip, maintaining high mixing efficiency, MF exerts higher of NP encapsulation efficiency (EE) than conventional methods. MF-NPs-cabazitaxel (CTX) particles (MF-NPs-CTX) were first prepared by encapsulating CTX according to MF. Folate (FA)- Polyethylene glycol (PEG)-NPs-CTX particles (FA-PEG-NPs-CTX) were formulated by connecting FA to MF-NPs-CTX to endow NPs with targeted delivery capability. Accordingly, the mean particle size of FA-PEG-NPs-CTX increased by approximately 25 nm, as compared with MF-NPs-CTX. Upon morphological observation of FA-PEG-NPs-CTX and MF-NPs-CTX by transmission electron microscopy (TEM), all NPs were spherical and particle size distribution was uniform. Moreover, the increased delivery efficiency of CTX in vitro and its strong tumor inhibition in vivo indicated that FA-PEG-NPs-CTX had a powerful tumor-suppressive effect both in vitro and in vivo. In vivo imaging and pharmacokinetic data confirmed that FA-PEG-NPs-CTX had good drug delivery efficiency. Taken together, FA-PEG-NPs-CTX particles prepared using MF showed high efficient and targeted drug delivery and may have a considerable driving effect on the clinical application of targeting albumin NPs.",
keywords = "Albumin nanoparticle, Cabazitaxel, Folate receptor, Microfluidic",
author = "Fanchao Meng and Yating Sun and Lee, {Robert J.} and Guiyuan Wang and Xiaolong Zheng and Huan Zhang and Yige Fu and Guojun Yan and Yifan Wang and Weiye Deng and Emily Parks and Kim, {Betty Y.S.} and Zhaogang Yang and Wen Jiang and Lesheng Teng",
year = "2019",
month = "10",
doi = "10.3390/cancers11101571",
language = "English (US)",
volume = "11",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel

AU - Meng, Fanchao

AU - Sun, Yating

AU - Lee, Robert J.

AU - Wang, Guiyuan

AU - Zheng, Xiaolong

AU - Zhang, Huan

AU - Fu, Yige

AU - Yan, Guojun

AU - Wang, Yifan

AU - Deng, Weiye

AU - Parks, Emily

AU - Kim, Betty Y.S.

AU - Yang, Zhaogang

AU - Jiang, Wen

AU - Teng, Lesheng

PY - 2019/10

Y1 - 2019/10

N2 - Microfluidic technology (MF) has improved the formulation of nanoparticles (NPs) by achieving uniform particle size distribution, controllable particle size, and consistency. Moreover, because liquid mixing can be precisely controlled in the pores of the microfluidic chip, maintaining high mixing efficiency, MF exerts higher of NP encapsulation efficiency (EE) than conventional methods. MF-NPs-cabazitaxel (CTX) particles (MF-NPs-CTX) were first prepared by encapsulating CTX according to MF. Folate (FA)- Polyethylene glycol (PEG)-NPs-CTX particles (FA-PEG-NPs-CTX) were formulated by connecting FA to MF-NPs-CTX to endow NPs with targeted delivery capability. Accordingly, the mean particle size of FA-PEG-NPs-CTX increased by approximately 25 nm, as compared with MF-NPs-CTX. Upon morphological observation of FA-PEG-NPs-CTX and MF-NPs-CTX by transmission electron microscopy (TEM), all NPs were spherical and particle size distribution was uniform. Moreover, the increased delivery efficiency of CTX in vitro and its strong tumor inhibition in vivo indicated that FA-PEG-NPs-CTX had a powerful tumor-suppressive effect both in vitro and in vivo. In vivo imaging and pharmacokinetic data confirmed that FA-PEG-NPs-CTX had good drug delivery efficiency. Taken together, FA-PEG-NPs-CTX particles prepared using MF showed high efficient and targeted drug delivery and may have a considerable driving effect on the clinical application of targeting albumin NPs.

AB - Microfluidic technology (MF) has improved the formulation of nanoparticles (NPs) by achieving uniform particle size distribution, controllable particle size, and consistency. Moreover, because liquid mixing can be precisely controlled in the pores of the microfluidic chip, maintaining high mixing efficiency, MF exerts higher of NP encapsulation efficiency (EE) than conventional methods. MF-NPs-cabazitaxel (CTX) particles (MF-NPs-CTX) were first prepared by encapsulating CTX according to MF. Folate (FA)- Polyethylene glycol (PEG)-NPs-CTX particles (FA-PEG-NPs-CTX) were formulated by connecting FA to MF-NPs-CTX to endow NPs with targeted delivery capability. Accordingly, the mean particle size of FA-PEG-NPs-CTX increased by approximately 25 nm, as compared with MF-NPs-CTX. Upon morphological observation of FA-PEG-NPs-CTX and MF-NPs-CTX by transmission electron microscopy (TEM), all NPs were spherical and particle size distribution was uniform. Moreover, the increased delivery efficiency of CTX in vitro and its strong tumor inhibition in vivo indicated that FA-PEG-NPs-CTX had a powerful tumor-suppressive effect both in vitro and in vivo. In vivo imaging and pharmacokinetic data confirmed that FA-PEG-NPs-CTX had good drug delivery efficiency. Taken together, FA-PEG-NPs-CTX particles prepared using MF showed high efficient and targeted drug delivery and may have a considerable driving effect on the clinical application of targeting albumin NPs.

KW - Albumin nanoparticle

KW - Cabazitaxel

KW - Folate receptor

KW - Microfluidic

UR - http://www.scopus.com/inward/record.url?scp=85075143538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075143538&partnerID=8YFLogxK

U2 - 10.3390/cancers11101571

DO - 10.3390/cancers11101571

M3 - Article

AN - SCOPUS:85075143538

VL - 11

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 10

M1 - 1571

ER -